Osmetech's 2009 Revenues Rise 81 Percent

The British molecular diagnostics firm's revenues rose on increased sales of its cystic fibrosis genotyping test and a warfarin sensitivity test.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories